<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Intraatrial reentrant <z:hpo ids='HP_0001649'>tachycardia</z:hpo> (IART) is the most common long-term, surgical <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> sequela in patients with complex <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The management of IART is challenging </plain></SENT>
<SENT sid="2" pm="."><plain>Medications, catheter ablation therapy, and pacemaker therapy have <z:hpo ids='HP_0000001'>all</z:hpo> been utilized as treatment options </plain></SENT>
<SENT sid="3" pm="."><plain>Slower <z:hpo ids='HP_0001649'>tachycardia</z:hpo> cycle lengths and 1:1 atrioventricular conduction provide even more challenges with regard to detection and antitachycardia pacing </plain></SENT>
<SENT sid="4" pm="."><plain>We describe the use of the rate response feature as a means of patient-initiated cardioversion </plain></SENT>
</text></document>